Liver Function Tests Market Report 2025 (Global Edition)

Global Liver Function Tests Market Report 2025 Market Size Split by Product Outlook: (Alanine Aminotransferase Test, Aspartate Aminotransferase Test, Alkaline Phosphatase Test, Gamma GT Test, Albumin,...

Liver Function Tests Market Report Description

We have various report editions of Liver Function Tests Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Liver Function Tests Market Insights Video

Competitive Landscape of the Liver Function Tests Market

There are national as well as global competitors in the fiercely competitive liver function test market. Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific are important firms that dominate because of their sophisticated technology and wide-ranging distribution networks. New players concentrate on creative and affordable ways to serve underrepresented markets. Technological developments, such as point-of-care diagnostics and automated testing systems, are what fuel competition. Forming alliances with medical facilities and academic institutions is a typical tactic to increase market share. Regional firms, on the other hand, also contribute significantly to the market's diversity by providing reasonably priced solutions in emerging areas.

In January 2022, Siemens Healthineers introduced the Enhanced Liver Fibrosis (ELF) Test in the United States. The ELF Test is the first and only predictive blood test that De Novo has been authorized to commercialize for use in evaluating the course of NASH patients' diseases. (Source: https://www.siemens-healthineers.com/en-us/press-room/press-releases/elflaunchus) In May 2021, GENFIT, a late-stage biopharmaceutical business committed to enhancing the quality of life for patients with liver and metabolic disorders, introduced NASHnext, a new noninvasive diagnostic test for nonalcoholic steatohepatitis (NASH). Labcorp, a well-known international life sciences organization, is the only company offering the test in the United States and Canada. (Source: https://www.labcorp.com/genfit-announces-launch-labcorp-nashnextr-novel-noninvasive-diagnostic-test-powered-genfits-nis4tm)

Top Companies Market Share in Liver Function Tests Industry: (In no particular order of Rank)

• F.Hoffmann-La Roche Ltd (Switzerland)
• Alpha Laboratories Ltd (India)
• Abbott (U.S.)
• Biobase Biodusty (Shandong)
• Co.
• Ltd. (China)
• Thermo Fisher Scientific Inc (U.S.)
• ELITechGroup (France)
• Randox Laboratories Ltd (U.K.)
• HORIBA Ltd (Japan)
• Laboratory Corporation of America Holdings (U.S.).
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Liver Function Tests Market

Which Region Dominates the Liver Function Tests Market in 2024?

According to Cognitive Market Research, North America currently dominates the Liver Function Tests market, and the region is expected to have significant growth during the projected period. Growing health consciousness and the frequency of liver disease are driving the market for liver function tests in North America. Due to its high rates of obesity and diabetes, rising alcohol consumption, and sophisticated healthcare system, the United States dominates the market. The implementation of point-of-care testing and preventative healthcare further bolsters market expansion. The requirement for liver function tests is also growing in Canada as a result of government campaigns to raise awareness of liver health issues and an increase in fatty liver disease patients. With large investments in R&D to satisfy the rising need for accurate and quick testing solutions, both nations provide prospects for advancements in non-invasive testing and biomarker-based diagnostics.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The market for liver function tests in Asia-Pacific is expanding quickly due to factors such as higher awareness, improved access to healthcare, and an increase in the prevalence of liver disease. With a high prevalence of fatty liver disease and hepatitis, as well as government backing for innovative diagnostics, China leads the region. India offers prospects because of the rising incidence of diabetes and obesity as well as developing diagnostic capabilities. Advanced healthcare infrastructure and an emphasis on early detection are advantageous in Japan. Growing health consciousness and better medical facilities are also helping emerging economies like Vietnam and Indonesia. Opportunities for portable, automated, and reasonably priced liver testing solutions are available in the area to satisfy a range of medical requirements.

The current report Scope analyzes Liver Function Tests Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Liver Function Tests Market Analysis

According to Cognitive Market Research, the global Liver Function Tests market size was estimated at USD 34124.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 13649.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Liver Function Tests market with a market size of USD 10769.69 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Liver function tests (LFTs) are in great demand in the United States due to the high frequency of liver disorders such as hepatitis and non-alcoholic fatty liver disease (NAFLD), as well as sophisticated healthcare infrastructure and rising obesity rates.
• The Canada Liver Function Tests market had a market share of USD 1637.98 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Ageing populations with chronic illnesses, government healthcare efforts, and growing health awareness increase the need for routine LFTs in Canada.
• The Mexico Liver Function Tests market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 1242.13 million in 2024.

Europe Liver Function Tests Market Analysis

According to Cognitive Market Research, the global Liver Function Tests market size was estimated at USD 34124.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 10237.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• The United Kingdom Liver Function Tests market had a market share of USD 1719.87 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. Key factors in the UK include escalating alcohol consumption, public health initiatives, and the incorporation of LFTs into preventative healthcare initiatives.
• The France Liver Function Tests market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 941.84 million in 2024.
• According to Cognitive Market Research, the German Liver Function Tests market size was valued at USD 2027.00 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. Sophisticated diagnostic tools and a strong emphasis on liver disease research and development increase the need for LFTs in Germany.
• The Italy Liver Function Tests market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 880.41 million in 2024.
• The Russian Liver Function Tests market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 1586.79 million in 2024.
• The Spain Liver Function Tests market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 839.46 million in 2024
• The Luxembourg Liver Function Tests market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 317.36 million in 2024.
• The Portugal Liver Function Tests market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 214.98 million in 2024.
• The Greece Liver Function Tests market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 122.85 million in 2024.
• The Rest of Europe's Liver Function Tests market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 1586.79 million in 2024.

Asia Pacific Liver Function Tests Market Analysis

According to Cognitive Market Research, the global Liver Function Tests market size was estimated at USD 34124.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 7848.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Liver Function Tests market size was valued at USD 3531.89 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. The liver function tests market in China is driven by a sizable patient population with liver cancer and hepatitis, as well as government funding for the development of healthcare infrastructure.
• The Japan Liver Function Tests market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 1083.11 million in 2024.
• The India Liver Function Tests market had a market share of USD 941.84 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. The need for reasonably priced LFTs in India has been increased by an increase in the prevalence of obesity, diabetes, and hepatitis, as well as improved access to healthcare in both urban and rural areas.
• The South Korean Liver Function Tests market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 784.86 million in 2024.
• The Australian Liver Function Tests market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 408.13 million in 2024.
• The South East Asia Liver Function Tests market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 541.56 million in 2024.
• The Rest of Asia Pacific Liver Function Tests market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 557.25 million in 2024.

South America Liver Function Tests Market Analysis

According to Cognitive Market Research, the global Liver Function Tests market size was estimated at USD 34124.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 1706.23 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Liver Function Tests market size was valued at USD 730.26 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Brazil's market is boosted by rising liver disease prevalence brought on by changes in lifestyle and improved diagnostic capabilities.
• Argentina's Liver Function Tests market had a market share of USD 286.65 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. In Argentina, the use of LFTs is growing as a result of the expansion of private healthcare facilities and increased knowledge of liver health.
• Colombia Liver Function Tests market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 151.85 million in 2024.
• Peru Liver Function Tests market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 139.91 million in 2024.
• Chile's Liver Function Tests market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 122.85 million in 2024.
• The Rest of Latin America's Liver Function Tests market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 274.70 million in 2024.

Middle East Liver Function Tests Market Analysis

According to Cognitive Market Research, the global Liver Function Tests market size was estimated at USD 34124.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 682.49 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031..

• The GCC Countries Liver Function Tests market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 292.11 million in 2024. LFT adoption is supported by high rates of obesity, diabetes, and liver diseases linked to alcohol consumption, as well as a growing emphasis on healthcare modernization in GCC countries.
• The Egypt Liver Function Tests market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 71.66 million in 2024.
• The South Africa Liver Function Tests market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 107.83 million in 2024. The elevated incidence of liver disorders like hepatitis and HIV-related liver problems, along with breakthroughs in diagnostic technology, encourages market expansion in South Africa.
• The Turkey Liver Function Tests market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 58.69 million in 2024.
• The Nigeria Liver Function Tests market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 71.66 million in 2024.
• The Rest of the MEA Liver Function Tests market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 80.53 million in 2024.

Liver Function Tests Market Analysis

How are Segments Performing in the Global Liver Function Tests Market?

Liver Function Tests Market Product Segment Analysis

According to Cognitive Market Research, Alanine Aminotransferase Test is likely to dominate the Liver Function Tests Market over the forecast period. Because of their vital role in the diagnosis and monitoring of liver disorders, Alanine Aminotransferase (ALT) tests are in high demand in the liver function tests market. A vital sign of liver health, ALT levels are frequently used to identify fatty liver disease, hepatitis, and liver damage brought on by drugs or alcohol. The need for ALT tests is greatly increased by the rising incidence of liver diseases, particularly non-alcoholic fatty liver disease (NAFLD), which is associated with diabetes and obesity. Regular ALT testing is also encouraged by heightened health consciousness and the focus on preventative healthcare. By guaranteeing precise and quick results, technological developments in automated and point-of-care testing systems also contribute to market expansion.

The Albumin is the fastest-growing segment in the Liver Function Tests Market. Due to their significance in evaluating liver function and general health, albumin tests are becoming more and more in demand in the liver function test market. A crucial protein that the liver produces, albumin aids in the detection of cirrhosis and hepatitis, among other chronic liver diseases. The need for these tests is being driven in large part by the rising prevalence of liver illnesses, which are caused by rising levels of alcohol intake, obesity, and diabetes. Furthermore, when chronic illnesses are being treated, liver health is regularly monitored with albumin testing. Advances in laboratory automation, along with the trend toward preventive healthcare and routine diagnostic screenings, are driving the global adoption of albumin testing.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Liver Function Tests Industry. Request a Free Sample PDF!

Liver Function Tests Market End-use Segment Analysis

According to Cognitive Market Research, the Disease Diagnose segment holds the largest share of the market. The vital role liver function tests (LFTs) play in identifying and tracking liver-related disorders is what drives the need for these tests in disease diagnosis. These procedures aid in the diagnosis of fatty liver disease, cirrhosis, hepatitis, and alcohol or drug-induced liver damage. As obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD) become more commonplace worldwide, LFTs are being used more and more for early identification and preventive management. Demand is also increased by their use in pre-operative evaluations, regulating drug toxicity, and monitoring chronic illnesses. LFTs are essential in clinical and diagnostic contexts because of the precise and quick results that automated and point-of-care testing, among other diagnostic technology advancements, contribute.

In the Liver Function Tests Market, Blood Routine Analysis has been expanding at a rapid pace. As liver function tests (LFTs) are incorporated into more thorough health evaluations, there is a growing need for them in routine blood analysis. By tracking bilirubin levels, protein synthesis, and liver enzyme levels, these tests are essential for gaining knowledge about the general health of the liver. Particularly in high-risk groups, LFTs are frequently included in regular blood studies to detect early indicators of liver diseases such as cirrhosis, fatty liver disease, and hepatitis. Demand is also driven by growing knowledge of routine health checkups and preventive healthcare. Furthermore, automated testing system improvements make LFTs in standard blood panels more efficient, which makes them a crucial part of contemporary diagnostic procedures.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Liver Function Tests Components Outlook: Segment Analysis

• Hepatocellular Labs
• Cholestasis Labs
• Synthetic Function Tests

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion